UroGen Pharma (UR8.STU) Q1 2026 Earnings

2MarConfirmed
Q1 2026
-0.46
-0.45
-0.44
-0.43

Details

Expected EPS
-0.42950282543999996
Actual EPS
-0.4616352
Surprise EPS
-0.03
Surprise Percent
+7.48%

Description

UroGen Pharma (UR8.STU) has reported earnings of -0.4616352 per share for Q1 2026.

0 Comments

Share your thoughts